Medicine and Dentistry
Apolipoprotein B48
18%
Biological Marker
8%
Cohort Analysis
20%
Diabetes
54%
Diabetes Mellitus
36%
Diabetes Prevention
5%
Drug Therapy
5%
Effusion
18%
End Stage Renal Disease
9%
Graft Failure
27%
Hazard Ratio
12%
High Density Lipoprotein Cholesterol
30%
High-Density Lipoprotein
18%
Homeostasis
6%
Insulin Resistance
18%
Kaplan Meier Method
5%
Ketone Bodies
18%
Kidney Graft
100%
Kidney Transplantation
19%
Lipoprotein
31%
Maturity Onset Diabetes of the Young
36%
Nephrology
9%
Obesity
5%
Population
36%
Proinsulin
18%
Proportional Hazards Model
12%
Quality of Life
9%
Resistance Index
18%
Triacylglycerol
9%
Keyphrases
ApoB48
18%
Apolipoprotein B-48
18%
Artificial Intelligence
18%
Body Type
18%
Chronic Kidney Disease
18%
Clinical Data Science
18%
Confidence Interval
11%
Cox Regression
7%
Cox Regression Analysis
8%
Diabetes
6%
Fasting Triglycerides
18%
Graft Outcome
5%
Hazard Ratio
11%
High-density Lipoprotein Cholesterol (HDL-C)
6%
High-density Lipoprotein Particles
18%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
9%
Hypertension
6%
Incident Type 2 Diabetes
54%
Intestine
5%
Kaplan-Meier Analysis
7%
Ketone Bodies
18%
Kidney Graft Failure
5%
Kidney Transplant Recipients
18%
Late Graft Failure
18%
New-onset Diabetes after Transplantation
18%
NMR Spectroscopy
5%
Post-transplant Diabetes Mellitus
18%
Potential Confounders
8%
Proinsulin
18%
Remnant Lipoprotein Cholesterol
18%
Renal Transplant Recipients
36%
Risk Factors
17%
Sex-stratified
7%
Statin Use
18%
Statins
18%
Triglyceride Level
18%
Triglycerides
25%
Type 2 Diabetes Mellitus (T2DM)
18%
Type 2 Diabetes Risk
11%